Title of Invention | ORAL CONTROLLED RELEASE FORMULATIONS |
---|---|
Abstract | Pharnlaceutical composition comprising a core containing Rivastigmine as a pharmaceutically active agent and coating comprising an inner film and an outer film, wherein the inner film comprises cellulose acetate and is pernleable to water and body fluids and hinders egress of the dissolved Rivastigmine out of the core, and the outer film comprises ethylcellulose and is pernleable to water and body fluids. |
Full Text |
---|
in-pct-2002-425-che abstract.pdf
in-pct-2002-425-che claims granted.pdf
in-pct-2002-425-che correspondence others.pdf
in-pct-2002-425-che correspondence po.pdf
in-pct-2002-425-che description (complete) granted.pdf
in-pct-2002-425-che form 1.pdf
in-pct-2002-425-che form 19.pdf
in-pct-2002-425-che form 3.pdf
in-pct-2002-425-che form 5.pdf
in-pct-2002-425-che petition.pdf
in-pct-2002-425-che power of attorney.pdf
Patent Number | 234121 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indian Patent Application Number | IN/PCT/2002/425/CHE | |||||||||||||||
PG Journal Number | 22/2009 | |||||||||||||||
Publication Date | 29-May-2009 | |||||||||||||||
Grant Date | 06-May-2009 | |||||||||||||||
Date of Filing | 20-Mar-2002 | |||||||||||||||
Name of Patentee | NOVARTIS AG | |||||||||||||||
Applicant Address | SCHWARZWALDALLEE 215, CH-4058, BASEL, | |||||||||||||||
Inventors:
|
||||||||||||||||
PCT International Classification Number | A61K 9/22 | |||||||||||||||
PCT International Application Number | PCT/EP00/09455 | |||||||||||||||
PCT International Filing date | 2000-09-27 | |||||||||||||||
PCT Conventions:
|